Acrivon Therapeutics | 4:持股變動聲明-高管 Peterson Katharine
Acrivon Therapeutics | 4:持股變動聲明-高管 Miller Mary
Acrivon Therapeutics | 4:持股變動聲明-高管 Masson Kristina
Acrivon Therapeutics | 4:持股變動聲明-高管 Holm-Jorgensen Rasmus
Acrivon Therapeutics | 4:持股變動聲明-高管 Gamelin Erick
Acrivon Therapeutics | 4:持股變動聲明-高管 Devroe Eric
Acrivon Therapeutics | 4:持股變動聲明-高管 Blume-Jensen Peter
Acrivon Therapeutics | 3:首次持股聲明-高管 Peterson Katharine
Acrivon Therapeutics | 4:持股變動聲明-高管 Miller Mary
Acrivon Therapeutics | 4:持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.
Acrivon Therapeutics | 4:持股變動聲明-股東 PERCEPTIVE ADVISORS LLC
Acrivon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%)等
Acrivon Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%)等
Acrivon Therapeutics | 4:持股變動聲明-董事 Palani Santhosh
Acrivon Therapeutics | 3:首次持股聲明-董事 Palani Santhosh
Acrivon Therapeutics | 4:持股變動聲明-高管 Masson Kristina
Acrivon Therapeutics | 4:持股變動聲明-高管 Miller Mary
Acrivon Therapeutics | 4:持股變動聲明-高管 Holm-Jorgensen Rasmus
Acrivon Therapeutics | 4:持股變動聲明-高管 Devroe Eric
Acrivon Therapeutics | 4:持股變動聲明-高管 Gamelin Erick
暫無數據